Calcitonin Gene-Related Peptide (CGRP) and the Pathophysiology of Headache: Therapeutic Implications

ISSN： 1172-7047

Source： CNS Drugs, Vol.15, Iss.10, 2001-01, pp. : 745-753

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine

By Durham Paul L. Vause Carrie V.

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 539-548

Adis International

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide: Vasoactive Effects and Potential Therapeutic Role

By Brain S.D. Cambridge H.

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 607-611

Elsevier

Access to resources Recommend Favorite

Calcitonin gene-related peptide as inflammatory mediator

By Springer J. Geppetti P. Fischer A. Groneberg D.A.

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 3, 2003-06 ,pp. : 121-130

Elsevier

Access to resources Recommend Favorite

The cardioprotection of calcitonin gene-related peptide-mediated preconditioning

By Li Y.-J. Peng J.

European Journal of Pharmacology, Vol. 442, Iss. 3, 2002-05 ,pp. : 173-177

Elsevier

Access to resources Recommend Favorite

Pharmacology of receptors for calcitonin gene-related peptide and amylin

By Poyner D.

Trends in Pharmacological Sciences, Vol. 16, Iss. 12, 1995-12 ,pp. : 424-428

Elsevier

Access to resources Recommend Favorite